Back to 
Wolverine Trading, LLC
Wolverine Trading, LLC
CRVS
2 quarters
Position history for Wolverine Trading, LLC's holdings in Corvus Pharmaceuticals, Inc.
No. Wolverine Trading exited its CRVS (Corvus Pharmaceuticals) position in Q4 2022. Its Q3 2022 13F listed 10,688 shares worth $8,000. Wolverine Trading first reported CRVS in Q3 2022 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$8,000
Total Shares Change
-10,688
Quarter-by-Quarter History
Other major holders of CRVS: BlackRock, Inc., State Street Corp., T. Rowe Price Associates, Inc.